25 companies

Celon Pharma

Market Cap: zł1.0b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.

CLN

zł19.60

7D

-0.5%

1Y

-14.8%

Selvita

Market Cap: zł554.3m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł30.00

7D

-0.5%

1Y

-6.0%

Bioceltix

Market Cap: zł509.0m

Engages in the development of stem cell-based biopharmaceuticals for veterinary use.

BCX

zł92.00

7D

3.8%

1Y

-8.9%

Captor Therapeutics Spolka Akcyjna

Market Cap: zł463.2m

A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.

CTX

zł72.20

7D

-2.4%

1Y

73.6%

Ryvu Therapeutics

Market Cap: zł360.2m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł15.30

7D

3.4%

1Y

-50.5%

BIOTON

Market Cap: zł329.7m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

BIO

zł3.83

7D

-0.5%

1Y

-8.4%

Synthaverse

Market Cap: zł207.6m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.

SVE

zł2.74

7D

-2.7%

1Y

-46.3%

Molecure

Market Cap: zł121.8m

A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.

MOC

zł5.85

7D

2.6%

1Y

-0.5%

Mabion

Market Cap: zł119.9m

A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.

MAB

zł7.46

7D

3.8%

1Y

-23.0%

Poltreg

Market Cap: zł114.8m

A biotechnology company, researches and develops therapies for autoimmune diseases.

PTG

zł19.30

7D

7.2%

1Y

-40.8%

NanoGroup

Market Cap: zł106.6m

Operates as a biotechnology company in Poland.

NNG

zł2.51

7D

-1.8%

1Y

-5.1%

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

HEN

zł2.32

7D

0%

1Y

-34.6%

Urteste

Market Cap: zł73.3m

Engages in the research and development of diagnostic tests for cancers.

URT

zł47.80

7D

2.6%

1Y

-2.4%

Genomtec

Market Cap: zł70.8m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

GMT

zł4.70

7D

-2.1%

1Y

-33.6%

Read-Gene

Market Cap: zł54.8m

Engages in the detection, prevention, and treatment of various types of cancer.

RDG

zł4.78

7D

1.9%

1Y

-4.4%

Biogened

Market Cap: zł45.4m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł18.50

7D

1.1%

1Y

-38.3%

Genomed Spólka Akcyjna

Market Cap: zł39.9m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł27.20

7D

-8.1%

1Y

5.4%

Medicofarma Biotech

Market Cap: zł28.7m

Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.

MDB

zł0.42

7D

3.0%

1Y

51.3%

Pure Biologics

Market Cap: zł25.8m

A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

PUR

zł2.11

7D

0.5%

1Y

-57.3%

genXone

Market Cap: zł20.0m

Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.

GX1

zł5.90

7D

-1.7%

1Y

-1.3%

Stem Cells Spin

Market Cap: zł16.9m

Operates as a biotechnology company in Poland.

SCS

zł0.41

7D

2.0%

1Y

28.1%

Green Zebras Spolka Akcyjna

Market Cap: zł15.5m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

GRZ

zł9.45

7D

5.6%

1Y

7.4%

Cannabis Poland

Market Cap: zł13.2m

Operates in the medical cannabis industry in Poland.

CBD

zł0.18

7D

-2.7%

1Y

-44.0%

Tecnovatica

Market Cap: zł5.7m

Does not have significant operations.

TEC

zł0.53

7D

3.1%

1Y

27.7%

Labocanna

Market Cap: zł4.6m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.22

7D

-1.4%

1Y

-27.2%